Edumedics Closes $4.2 Million Series A Financing

LOUISVILLE, KY (December 9, 2015) – Edumedics, an innovative healthcare delivery company that provides a complete care management solution for individuals who have—or are trending toward—diabetes and other chronic conditions, has closed $4.2 million in Series A financing.

According to Edumedics CEO Alice Shade, “Edumedics has proven that there’s a better way to provide services, one that has measurable engagement, quality and cost improvement. We are not only helping individuals live healthier, happier lives, we are doing it in a way that improves the allocation of resources, both in terms of money and clinical improvement.”

Edumedics will use the growth capital to expand to other states from its core populations in Kentucky and Maine. The funding will also accelerate the company’s unique offerings to Medicare groups who are challenged to achieve quality measures that impact HEDIS scores and Star ratings.

“Our healthcare system is ill-equipped to meet the challenges of affordability and to properly care for people trending toward chronic conditions,” said lead investor Bruce Lunsford of Lunsford Capital. “I am very impressed with the early results the Edumedics team has delivered for its clients—they are innovating with their proactive approach to care for those who have chronic conditions and are also providing a solid ROI for their clients.”

About Edumedics

Edumedics offers an innovative health care delivery model for populations like self-insured employers and Medicare Advantage groups. They put Nurse Practitioners face-to-face with individuals who have the daily challenge of managing diabetes and other chronic conditions—or who are trending in that direction. The Edumedics clinical team uses the company’s proprietary Healthward™ technology at the point of care. Results over the past four years show the company’s delivery model has clearly improved health and reduced costs for the groups they serve—up to a 15% reduction in yearly costs for clients enrolled in their programs, with significant improvement in clinical outcomes. For one client, diabetes improvement exceeded 52% among the most at risk members.

The company was founded in 2010 by Alice Shade and Dr. Richard Goldstein. While working at physician services company UPA Services and the University of Louisville respectively, the founders recognized that employees with chronic conditions – such as diabetes and hypertension – often account for up to 75 percent of a company’s medical costs, yet did not often times receive the necessary and appropriate care to best manage their condition. They developed the initial Intellectual Property while working on the problem for U of L’s employees, and later licensed the technology and spun out the company to deliver care to other populations.

Mark Crane, a Louisville-based health care executive and former E&Y Entrepreneur of the Year, joined Edumedics as COO in August, 2014 and helped lead the company’s $4.2M Series A financing. Crane worked closely with Louisville-based Venture First to identify and secure the group of investors, which includes both local and national players.

About the investors

Lunsford Capital, LLC led the round, joined by Chicago-based OCA Ventures and syndicate of angel investors and seed funds. Among them: Entrepreneur and Chrysalis Ventures Co-founder Doug Cobb, Enterprise Angels Fund, and 13 individuals geographically dispersed from Chicago to Florida.

Prior investors in the company who participated in the Series A round include University of Louisville Foundation, Kentucky Science and Technology Corporation, and Commonwealth Seed Capital Fund.

In conjunction with the financing, Bruce Lunsford, Chairman and CEO of Lunsford Capital, and Mike Stigler, Director of Blue & Co., LLC, have joined the Edumedics board of directors. Bob Saunders, General Partner with OCA Ventures, has joined as a board observer. Investors Jack Danehy, Todd Taylor, Bob Dunn, and Bob Saunders will serve on the company’s newly-formed Sales Advisory Board to provide input and leadership to the company’s expanded sales force.